Investigating the Impact of Sustainability Strategies in Biotechnology During Health Crises
Jamshidian, Aida (2025)
2025
All rights reserved. This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:amk-2025082524124
https://urn.fi/URN:NBN:fi:amk-2025082524124
Tiivistelmä
This thesis investigates how sustainability strategies influence the performance of biotechnology firms in Iran, particularly in the context of global health crises such as the COVID-19 pandemic. As health emergencies continue to expose vulnerabilities in operational systems, the role of sustainability in shaping more resilient, cost-effective, and competitive organizations has become increasingly important.
Using a mixed-methods approach, the research combines ten semi-structured interviews with a structured survey of 100 biotechnology professionals. The results indicate that companies implementing sustainability practices experienced measurable benefits across multiple performance dimensions. Specifically, 82 percent of participants reported enhanced operational efficiency, 74 percent observed significant cost reduction and improved resource optimization, and 68 percent noted stronger crisis management capabilities and long-term competitiveness.
Qualitative findings supported these insights, highlighting how sustainability-focused organizations were more adaptable during disruptions and better equipped to maintain performance under pressure. Despite these benefits, the study also identifies ongoing challenges, including limited access to green technology financing, lack of ESG expertise, and weak alignment between national policies and industrial sustainability goals.
The thesis concludes with actionable recommendations aimed at helping biotechnology firms and policymakers foster greater resilience and efficiency through sustainability-centered innovation. Emphasizing cost and resource efficiency, strategic planning, and crisis readiness, these findings offer a practical framework for navigating future health crises while enhancing overall sector performance.
Using a mixed-methods approach, the research combines ten semi-structured interviews with a structured survey of 100 biotechnology professionals. The results indicate that companies implementing sustainability practices experienced measurable benefits across multiple performance dimensions. Specifically, 82 percent of participants reported enhanced operational efficiency, 74 percent observed significant cost reduction and improved resource optimization, and 68 percent noted stronger crisis management capabilities and long-term competitiveness.
Qualitative findings supported these insights, highlighting how sustainability-focused organizations were more adaptable during disruptions and better equipped to maintain performance under pressure. Despite these benefits, the study also identifies ongoing challenges, including limited access to green technology financing, lack of ESG expertise, and weak alignment between national policies and industrial sustainability goals.
The thesis concludes with actionable recommendations aimed at helping biotechnology firms and policymakers foster greater resilience and efficiency through sustainability-centered innovation. Emphasizing cost and resource efficiency, strategic planning, and crisis readiness, these findings offer a practical framework for navigating future health crises while enhancing overall sector performance.